|
IE20000918A1
(en)
*
|
1990-03-22 |
2001-05-30 |
Sloan Kettering Inst Cancer |
GP75 As a Tumor Vaccine for Melanoma
|
|
US6180604B1
(en)
|
1996-08-21 |
2001-01-30 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using analogues of indolicidin
|
|
US6503881B2
(en)
*
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
|
WO1999043357A1
(en)
*
|
1998-02-25 |
1999-09-02 |
Micrologix Biotech Inc. |
Indolicidin and cationic peptides conjugated with polymers
|
|
US6303575B1
(en)
*
|
1998-05-12 |
2001-10-16 |
The Regents Of The University Of California |
Indolicidin analogs and methods of using same
|
|
WO1999065506A2
(en)
*
|
1998-06-12 |
1999-12-23 |
Micrologix Biotech Inc. |
Cancer therapy with indolicidin or cationic peptides and their polymer conjugates
|
|
US6444645B1
(en)
*
|
1998-06-18 |
2002-09-03 |
The Regents Of The University Of California |
Crosslink-stabilized indolicidin analogs
|
|
US6288212B1
(en)
*
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
|
WO2000026344A1
(en)
*
|
1998-10-30 |
2000-05-11 |
Interlink Biotechnologies Llc |
Peptides with enhanced stability to protease degradation
|
|
US6946261B1
(en)
|
1998-11-20 |
2005-09-20 |
Migenix Inc. |
Efficient methods for producing anti-microbial cationic peptides in host cells
|
|
EP1185623A4
(en)
*
|
1999-03-03 |
2005-03-23 |
Regents Board Of |
Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors
|
|
US6309633B1
(en)
*
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
|
US6576224B1
(en)
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US6429211B1
(en)
*
|
2000-05-23 |
2002-08-06 |
Bayer Corporation |
Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
|
|
PL363153A1
(en)
*
|
2000-06-16 |
2004-11-15 |
Hercules Incorporated |
Chemically-modified antimicrobial peptides, compositions and methods of production and use
|
|
KR20090089922A
(ko)
|
2000-10-18 |
2009-08-24 |
파마셋 인코포레이티드 |
바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드
|
|
US7214364B2
(en)
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
|
DK2301524T3
(da)
|
2000-12-27 |
2013-07-15 |
Gilead Sciences Inc |
Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner
|
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
|
US7115572B2
(en)
*
|
2001-03-29 |
2006-10-03 |
Council Of Scientific And Industrial Research |
Indolicidin analogs with anti-microbial activity
|
|
US6759058B1
(en)
*
|
2001-04-25 |
2004-07-06 |
Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences |
Enteric-coated proliposomal formulations for poorly water soluble drugs
|
|
US8658202B2
(en)
|
2001-04-25 |
2014-02-25 |
Western University Of Health Sciences |
Coated drug delivery formulations
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
EP1401478A2
(en)
*
|
2001-06-22 |
2004-03-31 |
The Hospital for Sick Children |
Antimicrobial peptides
|
|
US6835536B2
(en)
|
2001-08-21 |
2004-12-28 |
Micrologix Biotech Inc. |
Antimicrobial cationic peptides and formulations thereof
|
|
US6734165B2
(en)
*
|
2001-08-23 |
2004-05-11 |
The Trustees Of Columbia University In The City Of New York |
Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide
|
|
US8933029B2
(en)
*
|
2001-08-24 |
2015-01-13 |
Carrus Capital Corporation |
Antimicrobial and anti-inflammatory peptides
|
|
US7166571B2
(en)
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US7312192B2
(en)
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
|
US20030219854A1
(en)
*
|
2002-03-21 |
2003-11-27 |
Micrologix Biotech Inc. |
Methods for producing modified anti-infective peptides
|
|
US7399583B2
(en)
*
|
2002-04-17 |
2008-07-15 |
Novartis Ag |
Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein
|
|
AU2003231471A1
(en)
*
|
2002-04-25 |
2003-11-10 |
Toagosei Co., Ltd. |
Antimicrobial polypeptide and utizliation thereof
|
|
US7345018B2
(en)
|
2002-04-25 |
2008-03-18 |
Reception Aps |
Method of treating side effects induced by therapeutic agents
|
|
WO2003105768A2
(en)
|
2002-06-13 |
2003-12-24 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
|
IL150907A
(en)
*
|
2002-07-25 |
2007-07-04 |
Stephan Cherkez |
Process for the preparation of stable amorphous calcium pseudomonate
|
|
SE0202613D0
(sv)
|
2002-09-04 |
2002-09-04 |
Innate Pharmaceuticals Ab |
Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning
|
|
US7238669B2
(en)
*
|
2002-09-11 |
2007-07-03 |
The Curators Of The University Of Missouri |
Phage-display peptides as novel antimicrobial agents against Haemophilus influenzae
|
|
US20050245582A1
(en)
*
|
2002-09-12 |
2005-11-03 |
The Hartz Mountain Corporation |
High concentration topical insecticides containing pyrethroids
|
|
WO2005014777A2
(en)
*
|
2002-10-16 |
2005-02-17 |
Board Of Regents, The University Of Texas System |
Methods and compositions for increasing the efficacy of biologically-active ingredients
|
|
KR20110079783A
(ko)
|
2003-02-19 |
2011-07-07 |
예일 유니버시티 |
항-바이러스 뉴클레오시드 유사체 및 바이러스 감염, 특히 에이치아이브이 감염의 치료방법
|
|
US20040260454A1
(en)
*
|
2003-06-11 |
2004-12-23 |
Basir Otman A. |
Vibro-acoustic engine diagnostic system
|
|
US7189403B2
(en)
*
|
2003-06-30 |
2007-03-13 |
Institut Pasteur |
Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
|
|
US20050171063A1
(en)
*
|
2003-10-20 |
2005-08-04 |
Pawan Malhotra |
Use of phosphono derivatives as anti-malarials
|
|
WO2005039557A1
(en)
*
|
2003-10-22 |
2005-05-06 |
Council Of Scientific And Industrial Research |
Use of selected amino acid-zinc complexes as anti-malarial
|
|
US7674771B2
(en)
*
|
2003-10-29 |
2010-03-09 |
Toagosei Co., Ltd |
Antimicrobial peptides and utilization of the same
|
|
CA2559208A1
(en)
*
|
2004-03-17 |
2005-09-29 |
Mpex Pharmaceuticals, Inc. |
Use and administration of bacterial efflux pump inhibitors
|
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
|
WO2005090385A2
(en)
*
|
2004-03-18 |
2005-09-29 |
Ansata Therapeutics, Inc. |
Compositions having antimicrobial activity and uses thereof
|
|
CN101027318B
(zh)
|
2004-07-19 |
2016-05-25 |
比奥孔有限公司 |
胰岛素-低聚物共轭物，制剂及其用途
|
|
JP4507080B2
(ja)
*
|
2004-07-30 |
2010-07-21 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
|
US7588885B2
(en)
*
|
2004-08-06 |
2009-09-15 |
Chung Yuan Christian University |
Use of biocistronic DNA constructs for identifying compounds that inhibit IRES-dependent translation
|
|
US20060068020A1
(en)
*
|
2004-09-24 |
2006-03-30 |
Cottrell Ian W |
Encapsulated pharmaceutical agents
|
|
JP4730584B2
(ja)
*
|
2004-12-06 |
2011-07-20 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
|
EP1849474B1
(en)
*
|
2005-02-15 |
2016-09-07 |
Toagosei Co., Ltd. |
Antimicrobial peptide and use thereof
|
|
CA2617133C
(en)
|
2005-07-28 |
2014-09-30 |
Biosynexus Incorporated |
Compositions and methods for treating bacteria
|
|
US20090099062A1
(en)
*
|
2007-05-31 |
2009-04-16 |
Ethan Lee |
Pyrvinium For The Treatment of Cancer
|
|
US9241908B2
(en)
|
2007-10-16 |
2016-01-26 |
Biocon Limited |
Orally administrable solid pharmaceutical composition and a process thereof
|
|
ES2559840T3
(es)
*
|
2008-06-04 |
2016-02-16 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
JP2011195451A
(ja)
*
|
2008-06-20 |
2011-10-06 |
Fukuoka Univ |
ペプチド
|
|
US8773662B2
(en)
*
|
2010-07-22 |
2014-07-08 |
Vuv Analytics, Inc. |
Methods and apparatus for vacuum ultraviolet (VUV) or shorter wavelength circular dichroism spectroscopy
|
|
WO2012017215A1
(en)
*
|
2010-08-05 |
2012-02-09 |
Helperby Therapeutics Limited |
Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine
|
|
CN102167731B
(zh)
*
|
2011-02-10 |
2013-01-23 |
周逸明 |
一种固相多肽合成奥米加南的制备方法
|
|
WO2013056003A2
(en)
|
2011-10-12 |
2013-04-18 |
Yale University |
Catechol diethers as potent anti-hiv agents
|
|
AU2014318837B2
(en)
*
|
2013-09-12 |
2019-05-30 |
Janssen Biopharma, Inc. |
Pyridazinone compounds and uses thereof
|
|
WO2015077057A1
(en)
*
|
2013-11-20 |
2015-05-28 |
Texas Southern University |
Methionine aminopeptidase inhibitors for treating infectious diseases
|
|
RU2678985C2
(ru)
*
|
2017-02-06 |
2019-02-05 |
Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" |
Биоцидный пептид и препарат на его основе
|
|
CN108721292B
(zh)
*
|
2018-05-04 |
2022-04-01 |
中国疾病预防控制中心病毒病预防控制所 |
扑蛲灵在制备广谱抗冠状病毒药物中的应用
|
|
US12702790B2
(en)
|
2019-06-13 |
2026-08-11 |
Hollister Incorporated |
Reusable urinary catheter kits
|
|
LT3952973T
(lt)
|
2019-06-13 |
2023-07-10 |
Hollister Incorporated |
Daugkartinio naudojimo šlapimo kateterio produktai
|
|
WO2020263859A1
(en)
|
2019-06-25 |
2020-12-30 |
Hollister Incorporated |
Reusable urinary catheter products
|
|
KR102433665B1
(ko)
*
|
2021-11-17 |
2022-08-19 |
주식회사 씨위드 |
인돌리시딘 유래 항균 펩타이드 및 이의 용도
|